Evidence map›Paper›PMID 42755492›Full record

ArticleFrontiers in immunology2026

Ailén Fretes, Brenda Lara, Guillermina Calo, Ignacio Rojas Campión, Lourdes Materazzi, Florencia Sabbione, Stefania A Robaldi, Maria Constanza Pautasso, Claudia Pérez Leirós, Daiana Vota and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ailén Fretes *Universidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Brenda Lara *Universidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Guillermina CaloUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Ignacio Rojas CampiónUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Lourdes MaterazziUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Florencia SabbioneInstituto de medicina experimental (IMEX)-Consejo Nacional de Investigaciones Científicas y Técnicas (National Scientific and Technical Research Council)/Academia Nacional de Medicina de Buenos Aires, Buenos Aires, Argentina.
Stefania A RobaldiUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Maria Constanza PautassoUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Claudia Pérez LeirósUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Daiana VotaUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Paula M TribelliUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.
Vanesa HaukUniversidad de Buenos Aires - CONICET, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN)., Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: To address this, we evaluated the impact of PgOMV on human peripheral neutrophil activation, NET formation, metabolic parameters, and intracellular bacterial internalization and persistence, as well as their indirect effects on trophoblast migration. We further compared responses to OMV derived from bacteria grown under basal versus oxidative stress conditions (H Results: PgOMV induced neutrophil activation, as evidenced by increased ROS production and CD11b surface expression. Despite this activation, PgOMV did not trigger NET formation and significantly reduced extracellular DNA through DNase activity, as confirmed using PMA-induced NET preparations. PgOMV stimulation increased glucose uptake and lipid droplet accumulation, reduced lactate release, and decreased both mitochondrial mass and membrane potential. Neutrophils preconditioned with PgOMV displayed significantly greater Pg intracellular internalization and persistence relative to untreated controls, and conditioned media from PgOMV-stimulated neutrophils impaired HTR-8/SVneo trophoblast migration. Comparison of basal and H Conclusions: Together, these findings indicate that PgOMV induce an activated but permissive neutrophil phenotype characterized by activation, impaired extracellular antimicrobial responses, altered metabolic-associated parameters, and increased susceptibility to intracellular bacterial survival and that oxidative stress further enhances bacterial persistence. The impairment of trophoblast migration by PgOMV-conditioned neutrophil media supports an indirect, neutrophil-mediated mechanism through which periodontal-derived vesicles may contribute to placental dysfunction, with implications for the link between periodontitis and adverse pregnancy outcomes.

Indexed as

Bacterial Outer MembraneBacteroidaceae InfectionsExtracellular VesiclesNeutrophil ActivationNeutrophilsPorphyromonas gingivalisCell MovementExtracellular TrapsFemaleHumansOxidative StressPhenotypePregnancyReactive Oxygen SpeciesTrophoblastsReactive Oxygen Speciesimmune evasionneutrophilsperiodontal diseaseP. gingivalis outer membrane vesiclespregnancy complications

Identifiers

PMID42755492
PMCPMC13581572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.